Studies on the role of MALAT1 in inflammatory lung injury in COVID-19 have shown that downregulation of MALAT1 facilitates inflammatory injury by inhibiting neutrophil chemotaxis and immune cell infiltration at the infected site [8,135]. This evidence concerns the gene MALAT1 and COVID-19.